Federally-Listed PSOs

Below is a list of PSOs that are currently listed by AHRQ. A health care provider can only obtain the confidentiality and privilege protections of the Patient Safety Act by working with a Federally-listed PSO.

Use the categories on the left to filter the list of PSOs or search a PSO name.

Note: AHRQ updates the PSO information contained within the directories weekly, as needed; changes are made when there are newly listed PSOs and/or when existing information requires revision. Changes that would otherwise be effective on a weekend day or holiday will be effective on the next business day. Information contained in the directories is based on attestations that the PSOs provide. To update PSO contact information, please use the Change of Listing Information form; to update profile information, please go to the PSO PPC Web site.

There are 87 total PSOs listed by AHRQ.

PLEASE NOTE: To search for a PSO by State, use the 2 letter state abbreviation. Example: Kansas = KS

CHS PSO, LLC - P0122
Component of Parent Org(s):
  • CHS/Community Health Systems, Inc.
Effective Date and Time of Initial Listing: January 11, 2012 12:01 AM ET
PSO Mailing Address: 4000 Meridian Boulevard, Franklin, TN 37067
PSO Phone Number: (615) 465-7000
Point of Contact: Terrie Van Buren RN, BSN, MBA, CPPS
Point of Contact Phone: 615-465-7518
Point of Contact Email: terrie_vanburen@chs.net (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 01/11/2020 through 01/10/2022
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
ECRI Institute PSO - P0008
Component of Parent Org(s):
  • ECRI Institute
Effective Date and Time of Initial Listing: November 5, 2008 12:01 AM ET
PSO Mailing Address: 5200 Butler Pike, Plymouth Meeting, PA 19462
PSO Phone Number: 866-247-3004
Point of Contact: Sheila Rossi MHA
Point of Contact Phone: (610) 825-6000, ext. 5281
Point of Contact Email: srossi@ecri.org (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 11/05/2018 through 11/04/2020
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Kansas Clinical Improvement Collaborative Patient Safety Organization - P0184
Component of Parent Org(s):
  • Kansas Clinical Improvement Collaborative, LLC
Effective Date and Time of Initial Listing: December 7, 2016 12:01 AM ET
PSO Mailing Address: 2330 Shawnee Mission Parkway, Suite 300, Mail stop 5001, Westwood, KS 66205
PSO Phone Number: 913-945-7515
Point of Contact: Shelley Faye Boden
Point of Contact Phone: 785-324-1507
Point of Contact Email: shelley.boden@khsc-ku.com (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 12/07/2020 through 12/06/2022
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Nebraska Coalition for Patient Safety - P0076
Component of Parent Org(s):
  • Nebraska Academy of Physician Assistants
  • Nebraska Hospital Association
  • Nebraska Medical Association
  • Nebraska Nurses Association
  • Nebraska Pharmacists Association
  • Nebraska Pharmacists' Association
Effective Date and Time of Initial Listing: October 14, 2009 12:01 AM ET
PSO Mailing Address: 986055 Nebraska Medical Center, Omaha, NE 68198-6055
PSO Phone Number: 402-559-8421
Point of Contact: Gail E Brondum LPN
Point of Contact Phone: 402-559-8421
Point of Contact Email: gail.brondum@unmc.edu (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 10/14/2019 through 10/13/2021
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Virginia PSO - P0151
Component of Parent Org(s):
  • Virginia Hospital and Healthcare Association
  • Virginia Hospital Research and Education Foundation
Effective Date and Time of Initial Listing: September 11, 2013 12:01 AM ET
PSO Mailing Address: P.O. Box 31394, Richmond, VA 23294
PSO Phone Number: 804-965-1214
Point of Contact: Kristie Lynne Burnette
Point of Contact Phone: 804-965-1226
Point of Contact Email: kburnette@vhha.com (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 09/11/2021 through 09/10/2023
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No